Your browser doesn't support javascript.
loading
Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation.
Thomas, F; Maillard, M; Launay, M; Tron, C; Etienne-Grimaldi, M-C; Gautier-Veyret, E; Haufroid, V; Pallet, N; Royer, B; Narjoz, C; Schmitt, A.
Afiliación
  • Thomas F; Laboratory of Pharmacology, Claudius Regaud Institute, IUCT-O, Toulouse Cedex 09, France; Cancer Research Center of Toulouse, INSERM U1037/ERL5294 CNRS, Toulouse Cedex 01, France. Electronic address: thomas.fabienne@iuct-oncopole.fr.
  • Maillard M; Laboratory of Pharmacology, Claudius Regaud Institute, IUCT-O, Toulouse Cedex 09, France; Cancer Research Center of Toulouse, INSERM U1037/ERL5294 CNRS, Toulouse Cedex 01, France.
  • Launay M; Laboratory of Pharmacology and Toxicology, University Hospital Center of Saint-Etienne, Saint-Etienne Cedex 02, France.
  • Tron C; Laboratory of Pharmacology, University Hospital Center of Rennes, Rennes Cedex 09, France.
  • Etienne-Grimaldi MC; Laboratory of Pharmacology, UPRC EA 7497, Cancer Center Antoine Lacassagne, Nice Cedex 02, France.
  • Gautier-Veyret E; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital Center of Grenoble, INSERM U1042, Grenoble Cedex 09, France; HP2 Laboratory, Grenoble Alpes University, INSERM U1042, Grenoble, France.
  • Haufroid V; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Clinical and Experimental Research Institute (IREC), Université catholique de Louvain, Brussels, Belgium; Clinical Chemistry Department, Cliniques universitaires Saint-Luc, Brussels, Belgium.
  • Pallet N; Clinical Chemistry Department, Hôpital Européen Georges Pompidou, Assistance Publique-Hopitaux de Paris, Paris, France.
  • Royer B; Laboratory of Clinical Pharmacology and Toxicology, University Hospital Center of Besançon, Besançon Cedex, France.
  • Narjoz C; Clinical Chemistry Department, Hôpital Européen Georges Pompidou, Assistance Publique-Hopitaux de Paris, Paris, France.
  • Schmitt A; Department of Pharmacy, Centre Georges-François Leclerc, Dijon, France; INSERM U1231, University of Burgundy, Dijon, France.
Ann Oncol ; 32(6): 810-811, 2021 06.
Article en En | MEDLINE | ID: mdl-33662499
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Deficiencia de Dihidropirimidina Deshidrogenasa Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Deficiencia de Dihidropirimidina Deshidrogenasa Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article